ReviewCurrent allergy and asthma reports2026
When Hormones Attack: A Literature Review of Progesterone-Induced Anaphylaxis.
Review in Current allergy and asthma reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewProgesterone hypersensitivity is a rare and underdiagnosed condition whose incidence is expected to rise due to the increasing use of assisted reproductive technologies and exogenous progesterone exposure. This review aims to summarize the reported cases of endogenous and exogenous progesterone-induced anaphylaxis, focusing on clinical manifestations, diagnostic strategies, and management options. RECENT
findingsA literature search through three data bases identified 25 documented cases of progesterone-induced anaphylaxis. Both endogenous (n = 15) and exogenous (n = 10) exposures were implicated, with severe reactions including grade 4 (n = 12) and grade 5 (n = 1) anaphylaxis. Diagnostic evaluation commonly involved skin testing and challenge procedures, although heterogeneity in protocols was evident. Management strategies varied widely: some patients responded to hormonal modulation, while others required oophorectomy or treatment with monoclonal antibodies. Desensitization protocols were successfully implemented in selected cases, including in the context of in vitro fertilization. PH should be recognized as a potentially life-threatening condition, particularly relevant for women of reproductive age undergoing assisted reproduction or hormonal therapy. By combining clinical insights with published examples of successful diagnostic and therapeutic strategies, this review aims to support clinicians in recognizing progesterone-induced anaphylaxis and implementing patient-centered management. Increased awareness is essential for early diagnosis and individualized treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.